...
机译:14-3-3β施加胶质瘤促进效果,与胶质瘤患者的恶性进展和预后不良有关
Peoples Hosp Ningxiang Cty Dept Neurosurg Ningxiang 410600 Hunan Peoples R China;
Cent S Univ Dept Neurosurg Xiangya Hosp 87 Xiangya Rd Changsha 410078 Hunan Peoples R China;
Peoples Hosp Ningxiang Cty Dept Neurosurg Ningxiang 410600 Hunan Peoples R China;
Peoples Hosp Ningxiang Cty Dept Neurosurg Ningxiang 410600 Hunan Peoples R China;
Peoples Hosp Ningxiang Cty Dept Neurosurg Ningxiang 410600 Hunan Peoples R China;
Peoples Hosp Ningxiang Cty Dept Neurosurg Ningxiang 410600 Hunan Peoples R China;
Peoples Hosp Ningxiang Cty Dept Neurosurg Ningxiang 410600 Hunan Peoples R China;
Peoples Hosp Ningxiang Cty Dept Neurosurg Ningxiang 410600 Hunan Peoples R China;
Peoples Hosp Ningxiang Cty Dept Neurosurg Ningxiang 410600 Hunan Peoples R China;
glioma; 14-3-3 beta; oncogene; prognosis;
机译:14-3-3β施加胶质瘤促进效果,与胶质瘤患者的恶性进展和预后不良有关
机译:RAB38赋予不良预后,与神经胶质瘤的恶性进展和亚型偏爱相关
机译:恶性神经胶质瘤预后不良的姑息治疗
机译:MicroRNA分析在Gliomas的恶性进展中
机译:一种用于恶性神经胶质瘤定量层次图像分析的自动化系统:开发强大的技术,用于对多种胶质母细胞瘤进行整合的细分/分类和预后。
机译:14-3-3β发挥神经胶质瘤促进作用并与恶性胶质瘤患者的恶性进展和不良预后有关
机译:Hoxd11的异常表达促进了胶质瘤细胞的恶性行为,导致胶质瘤患者的预后差